Catalyst Funds Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,500
Closed -$278K 671
2025
Q4
$278K Hold
55,500
0.06% 245
2025
Q3
$281K Buy
55,500
+44,100
+387% +$194K 0.04% 338
2025
Q2
$49.1K Sell
11,400
-41,420
-78% -$205K 0.01% 374
2025
Q1
$319K Buy
+52,820
New +$267K 0.08% 261
2024
Q4
Sell
-12,000
Closed -$70.2K 900
2024
Q3
$70.2K Buy
12,000
+4,200
+54% +$20.7K 0.02% 637
2024
Q2
$33.6K Buy
+7,800
New +$37.4K 0.01% 528

Other funds holding MPT

Catalyst Funds Management's MPT Position: Q1 2026 in Review

Catalyst Funds Management sold out of Medical Properties Trust (MPT) in Q1 2026, closing a stake of 55,500 shares — an estimated $278K sold.

Catalyst Funds Management first reported a position in MPT in Q2 2024 and held it in 6 quarters. The position peaked at $319K in Q1 2025. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Catalyst Funds Management reported no remaining Medical Properties Trust position as of Q1 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 55,500 Medical Properties Trust shares in Q1 2026, an estimated $278K.
  • Catalyst Funds Management first reported a position in Medical Properties Trust in Q2 2024 and held it in 6 quarters.
  • Catalyst Funds Management's Medical Properties Trust position peaked at $319K in Q1 2025.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Catalyst Funds Management's 13F filing for Q1 2026, filed 11 May 2026.